pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Peptide Therapeutic · news · pharmadog
← back to Peptide Therapeutic
News · Peptide Therapeutic
94
stories
23d
Anthony Fauci’s pandemic-era diary entries
stat
24d
STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%
stat
24d
STAT+: Pharma’s drug spending deflection
stat
24d
Six wellness peptides win backing from FDA advisory committee
endpoints
24d
STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
stat
24d
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
stat
24d
STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
stat
24d
A trend that isn’t fading, ultra-processed baby foods
stat
24d
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
stat
25d
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
stat
25d
STAT+: Argenx to buy Forte Biosciences for $2.2B
stat
25d
EMA says it takes ultimate responsibility for protecting online meeting registration, survey information
raps
27d
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
stat
27d
STAT+: Fatal gene-editing trial in China raises ethics and oversight questions
stat
27d
STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
stat
27d
A new, separate outbreak of the diarrhea-causing parasite
stat
28d
FDA panel endorses broader use of certain peptides
biopharma dive
28d
FDA advisory committee backs two more peptides, rejects one for compounding list
raps
28d
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
stat
28d
Updated: FDA adcomm backs popular wellness peptides, despite staff concerns
endpoints
28d
U.S. health officials are investigating a new outbreak of a diarrhea-causing parasite
stat
28d
Chutes & Ladders—Biogen R&D vet gets in Formation
fiercebiotech
28d
STAT+: Popular insulin product enters shortage as other pens leave market
stat
28d
FDA panel confronting peptide controversy
stat
28d
STAT+: Trump administration quietly picks Timothy Westlake to lead mental health agency
stat
28d
Expect a clash at today’s FDA peptide panel
stat
28d
STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
stat
29d
STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
stat
29d
Australian biopharma Clinuvel to shed up to 20% of workforce in move to US
fiercebiotech
29d
Study: Most sponsors complete postmarketing trials, publish results
raps
← prev
page 2 of 4
next →
